U.S. patients seek stem cell treatments in China

06/6/2010 | Washington Post, The

Some U.S. patients with cerebral palsy and other diseases are undergoing experimental stem cell treatments in China, a trend that Western scientists say could jeopardize the health of patients. Moreover, the stem cells used in most clinics in the country are derived from miscarried fetuses, a practice that raises ethical and religious concerns.

View Full Article in:

Washington Post, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX